These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 13714488)

  • 21. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.
    PILLEMER L; LANDY M; SHEAR MJ
    J Exp Med; 1957 Jul; 106(1):99-110. PubMed ID: 13439118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
    Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
    [No Abstract]   [Full Text] [Related]  

  • 23. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [STUDY OF ANTIZYMOSAN AGGLUTININS IN IRRADIATED ANIMALS].
    SANNA G
    Minerva Radiol Fisioter Radiobiol; 1963 Nov; 14():507-12. PubMed ID: 14116760
    [No Abstract]   [Full Text] [Related]  

  • 25. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
    HOOK WA; CAREY WF; MUSCHEL LH
    J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative studies on the properdin-complement system.
    LEON MA
    J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE INFLUENCE OF ISOLATED PROPERDIN ON HELA-AND DETROIT 6-CELLS IN VITRO.
    RERABKOVA E; RYBAK M; PETAKOVA M; PESKOVA D
    Blut; 1964; 10():371-82. PubMed ID: 14281008
    [No Abstract]   [Full Text] [Related]  

  • 29. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
    Brade V; Vogt W
    Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 32. [Properdin system & antibody formation. II. Blood properdin picture of rabbits during immunization with Salmonella typhosa].
    WAHLIG H
    Arch Mikrobiol; 1959; 32(4):322-7. PubMed ID: 13650571
    [No Abstract]   [Full Text] [Related]  

  • 33. An alternative mechanism for the properdin system.
    NELSON RA
    J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Zymosan on the properdin level of tumor patients].
    NAGY S; HARTAI F
    Acta Biol Med Ger; 1961; 6():99-102. PubMed ID: 13727492
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
    MAZZEI D; TASCHINI P
    Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G
    Acta Biol Med Ger; 1962; 9():412-27. PubMed ID: 14003718
    [No Abstract]   [Full Text] [Related]  

  • 38. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the problem of nonspecific reaction of the body to the administration of the polysaccharide zymosan].
    SAMOILINA NL
    Probl Gematol Pereliv Krovi; 1961 Jan; 6():23-30. PubMed ID: 13745936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.